- Global Pharma News & Resources

Impact of Covid-19 on Allergy Immunotherapy Market 2026: Remarking Enormous Growth with Recent Trends | Aimmune Therapeutics, Hollister Allergy, Merck KGaA

: New York, United States, 15-July-2020, (Via WiredRelease), (Reports and Data) – The  Global Allergy Immunotherapy Market was calculated to be worth approximately USD 2.06 Billion in 2019 and is expected to reach around USD 4.64 Billion by 2027, growing at a CAGR of around 10.5% between 2020 and 2027. Allergy immunotherapy, also known as desensitization or hypo-sensitization and is used to treat environmental allergies like asthma and insect bites. The treatment includes subjecting the patient to massive amounts of allergens to alter the immune system’s response. The global allergy immunotherapy market is segmented based on types into Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy (SLIT), and Others. Subcutaneous immunotherapy or allergy shots involve injections of allergen extract and is administered only by a medical professional. Sublingual immunotherapy places drops or a tablet of allergen extracts under the tongue, which is then absorbed through the lining of the mouth.

 The Allergy Immunotherapy Market Report gives the most comprehensive and exhaustive coverage of the industry with business strategies as well as qualitative and quantitative analysis of the global market. It offers a detailed analysis of critical aspects of the Allergy Immunotherapy market (2019-2026). Analysts who have curated this report have provided in-depth information on drivers, restraints, challenges, trends, and opportunities to offer an extensive analysis of the Allergy Immunotherapy market.

Get a Free Sample PDF Report to understand our report before you purchase: @

The increasing incidences of food allergies among both adults and children is a primary driving factor for the growth of the global allergy immunotherapy market. Advancements in sublingual immunotherapies in emerging economies are also boosting the growth of the market. However, the side effects of allergy immunotherapy might hinder the growth of the market in the forecast period. These side effects can include mild to moderate skin or respiratory reactions, and in some instances, can also cause anaphylaxis. The report studies major companies that control a considerable portion of the overall market share.

Key participants include

Aimmune Therapeutics, Hollister Allergy, Leti Pharma, Merck KGaA (Allergopharma), Stallergenes Greer, Allergy Therapeutics, ALK-Abello A/S, HAL Allergy Group, and Circassia, among others.

Get Discount on the report @

For the purpose of this report, Reports and Data have segmented into the global Allergy Immunotherapy market on the basis of type, propellants, application, and region:

 Market segment based on Type of Immunotherapy:

Subcutaneous Immunotherapy (SCIT) Sublingual Immunotherapy (SLIT) Others

Market segment based on Allergy Type:

Allergic Rhinitis Asthma Food Allergy Others

Regional Outlook (Revenue, USD Million; 2017-2027)

North America S Europe K France Asia Pacific China India Japan MEA Latin America Brazil

For More Information, visit @

Key aspects of the Allergy Immunotherapy Market Report:

The report comprises of Allergy Immunotherapy market overview, market share, demand and supply ratio, supply chain analysis, and import/export details.

The report explores different strategies and procedures undertaken by key market players that assist in making profitable decisions.

The report covers all the crucial information about the products and services of major competitors.

About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.

Contact Us:
John Watson
Head of Business Development
Reports and Data | Web:
Direct Line: +1-212-710-1370

This content has been published by MARKETYSERS GLOBAL CONSULTING LLP company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at

Editor Details

Last Updated: 16-Jul-2020